Jazz Pharma's sleep disorder drug gets European panel backing

Jazz Pharma's sleep disorder drug gets European panel backing
Reuters: Health
Jazz Pharmaceuticals Plc's treatment for a form of sleep disorder has been recommended for approval in Europe by a panel of the European Medicines Agency (EMA), the regulator said on Friday.


No comments:

Post a Comment